NSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.
Cohance Lifesciences Ltd: key numbers
- Share price
- ₹433.00
- Market cap
- ₹16,566 Cr
- Revenue (annual)
- ₹2,269 Cr
- Net profit (annual)
- ₹179.2 Cr
- P/E (TTM)
- 155.9×Sector 42.0×
- Promoter holding
- 57.48%-0.01% QoQ
- FII holding
- 7.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cohance Lifesciences Ltd
All →Cohance Lifesciences Earnings Call Transcript: Key Takeaways
Q2 revenue rose about 13% QoQ to ₹477 Cr and adjusted EBITDA reached about ₹46 Cr (~10% margin), but both remain below last year. H2 YoY growth is promised without figures, and FY27 specialty chemicals guidance was cut to decline.
Cohance Lifesciences Investor Presentation: Key Takeaways
Q2FY27 revenue INR 4,766 Mn, down 14.2% YoY but up 12.9% QoQ. Adjusted EBITDA margin 9.6%, adjusted PAT INR 74 Mn back positive. Strategy centres on One Cohance integration and H2 recovery.
Cohance Lifesciences Q2 FY27 Results: Net Profit ₹2.3 Cr, Down 96.5% YoY
Cohance Lifesciences Ltd reported revenue from operations of ₹476.6 Cr (-14.2% YoY) and net profit of ₹2.3 Cr (-96.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.3 Cr · -96.5% YoY
Cohance Lifesciences Adverse Business Impact
Cohance Lifesciences disclosed a TGPCB closure order halting manufacturing at its Suryapet site after an industrial accident. The financial impact cannot yet be quantified.
Cohance Lifesciences Board Meeting Date
Cohance Lifesciences will hold a board meeting on 6 November 2026 to approve Q2 and half-year results. The trading window stays closed until 9 November 2026.
Cohance Lifesciences Other Announcement
Cohance Lifesciences Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b), disclosing promoter and public shareholding data as of September 30, 2026.
Other results update announcements
All →Supriya Lifescience Results Update
Supriya Lifescience's Q2 FY27 revenue rose 3.2%, but EBITDA and PAT fell sharply. Ambernath ramp-up costs and LATAM regulatory shifts hurt margins.
Bluspring Enterprises Results Update
Bluspring Enterprises' press release shows Q2 FY27 revenue up 49% YoY and PAT up 95%. Results exclude foundit, and no event value is assigned.
Capital India Finance Results Update
Capital India Finance's H1 FY27 press release shows standalone income up 44% to Rs 145.32 Crore. Disbursements rose 39% and AUM grew 25% year-on-year.
Anawil Wire & Engineering Results Update
Anawil reported H1FY27 revenue of Rs 153.97 Crore, up 272.2% YoY. PAT rose 539.3% to Rs 14.39 Crore; FY27 guidance is Rs 450-500 Crore revenue.
Transworld Shipping Lines Results Update
Transworld Shipping Lines reported Q2 FY27 consolidated PAT of Rs.56 Crore against a prior-year loss of Rs.11 Crore. Revenue was Rs.141 Crore versus Rs.143 Crore.
Prospect Consumer Products Results Update
Prospect Consumer Products reported H1 FY27 Total Income of Rs.31.10 Crore, up 4.75%, but PAT fell 29.83%. EBITDA margin compressed to 10.93% from 13.56%.